Omega Therapeutics Inc. (OMGA) NASDAQ

$3.65 0.10 (2.82%)

Market Cap: $201.27M

As of 03/28/24 04:00 PM EDT. Market closed.

(OMGA)

Omega Therapeutics Inc. (OMGA)
NASDAQ

$3.65
0.10 (2.82%)

Market Cap: $201.27M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for a range of disease ... read more

omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for a range of disease indications including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology. # transformativemedicines #pioneeringmedicines read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
PRICE CHART FOR OMEGA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.60
Previous Close
$3.55
Days Range
$3.34 - $3.57
52 week range
$1.30 - $10.09
Volume
275,219
Avg. Volume (30 days)
318,105
Market Cap
$201.27M
Dividend Yield
-
P/E
-
Shares Outstanding
55,141,838
Open
$3.60
Previous Close
$3.55
Days Range
$3.34 - $3.57
52 week range
$1.30 - $10.09
Volume
275,219
Avg. Volume (30 days)
318,105
Market Cap
$201.27M
Dividend Yield
-
P/E
-
Shares Outstanding
55,141,838
FINANCIAL STATEMENTS FOR OMEGA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OMEGA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Young Richard ADirectorJun 02, 2023 Sale$8.005,00040,000739,118Jun 05, 2023, 04:15 PM
Young Richard ADirectorMay 01, 2023 Sale$8.005,00040,000744,118May 03, 2023, 04:05 PM
Young Richard ADirectorApr 06, 2023 Sale$8.005,00040,000749,118Apr 10, 2023, 04:05 PM
Young Richard ADirectorMar 17, 2023 Sale$8.0010,00080,000754,118Mar 20, 2023, 04:05 PM
Flagship Pioneering Inc.10% OwnerFeb 27, 2023 Buy$5.781,329,3247,683,4931,329,324Feb 27, 2023, 05:20 PM
Flagship Pioneering Inc.10% OwnerFeb 27, 2023 Buy$5.781,993,98611,525,2397,508,693Feb 27, 2023, 05:20 PM
Young Richard ADirectorJan 10, 2023 Sale$8.0020,000160,000764,118Jan 11, 2023, 04:14 PM
Young Richard ADirectorSep 14, 2022 Sale$8.0010,00080,000784,118Sep 15, 2022, 04:10 PM
Karande MaheshPresident and CEOFeb 01, 2022 Option Exercise$0.5311,3005,989117,711Feb 03, 2022, 04:05 PM
Flagship Pioneering Inc.10% OwnerAug 03, 2021 Buy$17.001,176,46919,999,9738,617,413Aug 05, 2021, 05:43 PM
Flagship Pioneering Inc.10% OwnerAug 03, 2021 Buy$17.001,176,46919,999,9738,617,413Aug 05, 2021, 05:41 PM
Sawhney RogerChief Financial OfficerAug 03, 2021 Buy$17.002,94149,9972,941Aug 03, 2021, 05:16 PM
Invus Public Equities, L.P.10% OwnerJul 30, 2021 Buy$16.1475,0001,210,34275,000Aug 03, 2021, 05:16 PM
Invus Public Equities, L.P.10% OwnerAug 03, 2021 Buy$17.00875,00014,875,0002,273,530Aug 03, 2021, 05:16 PM
BERRY DAVID ADirectorAug 03, 2021 Buy$17.0053,082902,39453,082Aug 03, 2021, 05:15 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Young Richard ADirector06/02/202340,000
Young Richard ADirector05/01/202340,000
Young Richard ADirector04/06/202340,000
Young Richard ADirector03/17/202380,000
Flagship Pioneering Inc.10% Owner02/27/20237,683,493
Flagship Pioneering Inc.10% Owner02/27/202311,525,239
Young Richard ADirector01/10/2023160,000
Young Richard ADirector09/14/202280,000
Karande MaheshPresident and CEO02/01/20225,989
Flagship Pioneering Inc.10% Owner08/03/202119,999,973
Flagship Pioneering Inc.10% Owner08/03/202119,999,973
Sawhney RogerChief Financial Officer08/03/202149,997
Invus Public Equities, L.P.10% Owner07/30/20211,210,342
Invus Public Equities, L.P.10% Owner08/03/202114,875,000
BERRY DAVID ADirector08/03/2021902,394
Load More Insider Transactions
FUNDS WITH A POSITION IN OMEGA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,382,2800.00011%-9.65%Other
PLATINUM INVESTMENT MANAGEMENT LTD886,7820.11%-0.03%Growth At A Reasonable Price, Value
GEODE CAPITAL MANAGEMENT, LLC477,6380.00015%4.16%Other
RENAISSANCE TECHNOLOGIES LLC20,4000.00009%NewOther
CHANGE IN SHARES OUTSTANDING FOR OMEGA THERAPEUTICS INC
STOCK BUYBACKS FOR OMEGA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.12%
1Q
09/30/2023
03/31/2023
8.91%
2Q
09/30/2023
12/31/2022
14.85%
3Q
09/30/2023
09/30/2022
15.22%
4Q
09/30/2023
06/30/2022
15.24%
5Q
09/30/2023
03/31/2022
15.34%
6Q
09/30/2023
09/30/2021
70.69%
8Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.12%
1Q
03/31/2023
8.91%
2Q
12/31/2022
14.85%
3Q
09/30/2022
15.22%
4Q
06/30/2022
15.24%
5Q
03/31/2022
15.34%
6Q
09/30/2021
70.69%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OMEGA THERAPEUTICS INC
LOADING...